Null genotype of GSTT1 contributes to increased Parkinson’s disease risk in Caucasians: Evidence from a meta-analysis

Molecular Biology Reports

Volumn 41, Issue 11, 2014, Pages 7423-7430

  Wang, Dan ^a   Zhai, Jun Xia ^b   Zhang, Li Mei ^c   Liu, Dian Wu ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Institute of Hebei Medical Information   (China)

^c INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

Gene polymorphism; GSTT1; Meta analysis; Parkinson s disease

Indexed keywords

GLUTATHIONE TRANSFERASE T1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE;

ARTICLE; ASIAN; CASE CONTROL STUDY; CAUCASIAN; ETHNIC DIFFERENCE; ETHNICITY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GSTT1 GENE; HISPANIC; HUMAN; NULL ALLELE; PARKINSON DISEASE; RISK ASSESSMENT; SAMPLE SIZE; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; BIOLOGICAL MODEL; GENETICS; META ANALYSIS; RECESSIVE GENE; RISK;

EUROPEAN CONTINENTAL ANCESTRY GROUP; GENES, RECESSIVE; GENETIC ASSOCIATION STUDIES; GLUTATHIONE TRANSFERASE; HUMANS; MODELS, GENETIC; ODDS RATIO; PARKINSON DISEASE;

EID: 84917733542     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-014-3631-6     Document Type: Article

References (33)

1. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140:918–934
2. Moore DJ, West AB, Dawson VL, Dawson TM (2005) Molecular pathophysiology of Parkinson’s disease. Annu Rev Neurosci 28:57–87
3. Abu-Amero KK, Milcarek B, Bosley TM (2009) GSTM1 and GSTT1 deletion genotypes in various spontaneous optic neuropathies in Arabs. Br J Ophthalmol 93:1101–1104
4. Zhong S, Yang JH, Liu K, Jiao BH, Chang Z (2012) Null genotype of glutathione S-transferase Tl contributes to colorectal cancer risk in the Asian population: a meta-analysis. J Gastroenterol Hepatol 27:231–237
5. Hayes JD, Strange RC (2000) Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61:154–166
6. Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101–129
7. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560
8. Galbraith RF (1988) A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med 7:889–894
9. Bandmann O, Vaughan J, Holmans P, Marsden CD, Wood NW (1997) Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson’s disease. Lancet 350:1136–1139
10. De Palma G, Mozzoni P, Mutti A, Calzetti S, Negrotti A (1998) Case–control study of interactions between genetic and environmental factors in Parkinson’s disease. Lancet 352:1986–1987
11. Menegon A, Board PG, Blackburn AC, Mellick GD, Le Couteur DG (1998) Parkinson’s disease, pesticides, and glutathione transferase polymorphisms. Lancet 352:1344–1346
12. Stroombergen MC, Waring RH (1999) Determination of glutathione S-transferase mu and theta polymorphisms in neurological disease. Hum Exp Toxicol 18:141–145
13. Rahbar A, Kempkes M, Muller T, Reich S, Welter FL, Meves S, Przuntek H, Bolt HM, Kuhn W (2000) Glutathione S-transferase polymorphism in Parkinson’s disease. J Neural Transm 107:331–334
14. Ahmadi A, Fredrikson M, Jerregard H, Akerback A, Fall PA, Rannug A, Axelson O, Soderkvist P (2000) GSTM1 and mEPHX polymorphisms in Parkinson’s disease and age of onset. Biochem Biophys Res Commun 269:676–680
15. Kelada SN, Stapleton PL, Farin FM, Bammler TK, Eaton DL, Smith-Weller T, Franklin GM, Swanson PD, Longstreth WT Jr, Checkoway H (2003) Glutathione S-transferase M1, T1, and P1 polymorphisms and Parkinson’s disease. Neurosci Lett 337:5–8
16. Deng Y, Newman B, Dunne MP, Silburn PA, Mellick GD (2004) Case-only study of interactions between genetic polymorphisms of GSTM1, P1, T1 and Z1 and smoking in Parkinson’s disease. Neurosci Lett 366:326–331
17. Fong C, Cheng C, Wu R (2006) Modification of pesticide exposure in correlation with Glutathione Transferase (GST) polymorphisms for the susceptibility risk of sporadic Parkinson’s diseases. Mov Disord 21:S501–S502
18. Dick FD, De Palma G, Ahmadi A, Osborne A, Scott NW, Prescott GJ, Bennett J, Semple S, Dick S, Mozzoni P, Haites N, Wettinger SB, Mutti A, Otelea M, Seaton A, Soderkvist P, Felice A (2007) Gene-environment interactions in parkinsonism and Parkinson’s disease: the Geoparkinson study. Occup Environ Med 64:673–680
19. Wahner AD, Glatt CE, Bronstein JM, Ritz B (2007) Glutathione S-transferase mu, omega, pi, and theta class variants and smoking in Parkinson’s disease. Neurosci Lett 413:274–278
20. Singh M, Khan AJ, Shah PP, Shukla R, Khanna VK, Parmar D (2008) Polymorphism in environment responsive genes and association with Parkinson disease. Mol Cell Biochem 312:131–138
21. Kiyohara C, Miyake Y, Koyanagi M, Fujimoto T, Shirasawa S, Tanaka K, Fukushima W, Sasaki S, Tsuboi Y, Yamada T, Oeda T, Miki T, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M (2010) GST polymorphisms, interaction with smoking and pesticide use, and risk for Parkinson’s disease in a Japanese population. Parkinsonism Relat Disord 16:447–452
22. Matmurodov RJ, Khalimova KM, Raimova MM (2011) Polymorphism of the genes GSTM1, GSTT1, and environmental factors in the development of Parkinson’s disease among representatives of the Uzbek nationality. Eur J Neurol 18:S501
23. Goldman SM, Kamel F, Ross GW, Bhudhikanok GS, Hoppin JA, Korell M, Marras C, Meng C, Umbach DM, Kasten M, Chade AR, Comyns K, Richards MB, Sandler DP, Blair A, Langston JW, Tanner CM (2012) Genetic modification of the association of paraquat and Parkinson’s disease. Mov Disord 27:1652–1658
24. Biswas A, Sadhukhan T, Bose K, Ghosh P, Giri AK, Das SK, Ray K, Ray J (2012) Role of glutathione S-transferase T1, M1 and P1 polymorphisms in Indian Parkinson’s disease patients. Parkinsonism Relat Disord 18:664–665
25. Cornetta T, Patrono C, Terrenato I, De Nigris F, Bentivoglio AR, Testa A, Palma V, Poggioli T, Padua L, Cozzi R (2013) Epidemiological, clinical, and molecular study of a cohort of Italian Parkinson disease patients: association with glutathione-S-transferase and DNA repair gene polymorphisms. Cell Mol Neurobiol 33:673–680
26. Pinhel MA, Sado CL, Longo Gdos S, Gregorio ML, Amorim GS, Florim GM, Mazeti CM, Martins DP, Oliveira Fde N, Nakazone MA, Tognola WA, Souza DR (2013) Nullity of GSTT1/GSTM1 related to pesticides is associated with Parkinson’s disease. Arq Neuropsiquiatr 71:527–532
27. Ioannidis JP, Patsopoulos NA, Evangelou E (2007) Uncertainty in heterogeneity estimates in meta-analyses. BMJ 335:914–916
28. Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, Nelson LM (2003) Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 157:1015–1022
29. Dyba T, Kampenes VB, Sjoberg DIK (2006) A systematic review of statistical power in software engineering experiments. Inf Softw Technol 48:745–755
30. Chang WW, Su H, He L, Zhao KF, Wu JL, Xu ZW (2010) Association between transforming growth factor-beta1 T869C polymorphism and rheumatoid arthritis: a meta-analysis. Rheumatology (Oxford) 49:652–656
31. Ciccone S, Maiani E, Bellusci G, Diederich M, Gonfloni S (2013) Parkinson’s disease: a complex interplay of mitochondrial DNA alterations and oxidative stress. Int J Mol Sci 14:2388–2409
32. Zhang Y, Wang ZZ, Sun HM (2012) Lack of association between p.Ser167Asn variant of Parkin and Parkinson’s disease: a meta-analysis of 15 studies involving 2,280 cases and 2,459 controls. Am J Med Genet B 159B:38–47
33. Wang B, Huang G, Wang D, Li A, Xu Z, Dong R, Zhang D, Zhou W (2010) Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis. J Hepatol 53:508–518